Skip to content
  • Saturday, 15 August 2026
  • 12:13 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Cornell University Breakthrough Marks Significant Advance Toward Long-Acting Nonhormonal Male Contraceptive
Stem Cell & Regenerative Medicine

Cornell University Breakthrough Marks Significant Advance Toward Long-Acting Nonhormonal Male Contraceptive

Dwi Wanna Jul 20, 2026 0

In a landmark development for reproductive medicine, researchers at Cornell University have identified a biological pathway that could lead to…

Read More
Environmental & Analytical Chemistry

Short-acting methods matched long-acting options in a contraceptive initiative that centered users

Abdurrohim Arsyad Jul 10, 2026 0

A groundbreaking contraceptive initiative in Salt Lake City has revealed that when individuals are empowered to choose their preferred birth…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Identify Breakthrough Nonhormonal Path Toward Reversible Long Acting Male Contraception.

Dwi Wanna Jun 13, 2026 0

In a landmark advancement for reproductive science, researchers at Cornell University have announced a significant breakthrough in the quest for…

Read More
Stem Cell & Regenerative Medicine

Cornell University scientists develop a safe reversible and long-acting nonhormonal male contraceptive through targeted meiotic disruption

Dwi Wanna Apr 30, 2026 0

Researchers at Cornell University have announced a significant breakthrough in reproductive science, successfully demonstrating a method for nonhormonal male contraception…

Read More
UCB Acquires Neurona Therapeutics for Up to $1.15 Billion to Bolster Epilepsy Pipeline with Regenerative Cell TherapyGene Therapy Breakthrough Offers Non-Addictive Path for Chronic Pain Treatment via Brain-Specific Circuit TargetingMediterranean Diet Adherence Linked to Mitochondrial Microproteins Humanin and SHMOOSE as Potential Biological Pathways for Healthy AgingDatroway Receives FDA Approval for Metastatic Triple-Negative Breast Cancer, Marking a Significant Advancement in Targeted Therapy
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ